Contact info@epaad.org for more information
  • Home
  • Knowledge
    • Introduction
    • Publications
  • Data
    • Gene Expresssion Database
    • Metabolomics Database
  • Resources
    • Antibodies
    • Animal Models
  • APOE U19
  • About us
  • Home
  • Knowledge
    • Introduction
    • Publications
  • Data
    • Gene Expresssion Database
    • Metabolomics Database
  • Resources
    • Antibodies
    • Animal Models
  • APOE U19
  • About us

ApoE and Other Neurodegenerative Disorders

Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Robinson, J. L., Lee, E. B., Xie, S. X., Rennert, L., Suh, E., Bredenberg, C., Caswell, C., Van Deerlin, V. M., Yan, N., Yousef, A., Hurtig, H. I., Siderowf, A., Grossman, M., McMillan, C. T., Miller, B., Duda, J. E., Irwin, D. J., Wolk, D., Elman, L., McCluskey, L., Trojanowski, J. Q. (2018).  Brain : a journal of neurology, 141(7), 21812193.

Gene-environment interaction between lead and Apolipoprotein E4 causes cognitive behavior deficits in mice. Engstrom AK, Snyder JM, Maeda N, Xia Z.  Mol Neurodegener. 2017 Feb 7;12(1):14.

Latest Publications

  • ApoE and α-synuclein
  • ApoE and Aging
  • ApoE and Alzheimer’s Disease
  • ApoE and Inflammation
  • ApoE and Other Diseases
  • ApoE and Other Neurodegenerative Disorders
  • ApoE and TDP-43
  • ApoE and Vasculature
  • ApoE Review
  • ApoE4 attenuates cortical neuronal activity in young behaving apoE4 rats

Join Our Newsletter

Success!

SIGN UP

info@epaad.org

Copyright © 2023 EPAAD

Site by Jax Media Team